EFM
ORIC icon

E Fund Management’s Oric Pharmaceuticals ORIC Stock Holding History

E Fund Management’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$139K Sell
12,798
-1,719
-12% -$15.6K ﹤0.01% 467
2026
Q1 		$184K Buy
+14,517
New +$165K 0.01% 455

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

E Fund Management's ORIC Position: Q2 2026 in Review

E Fund Management reduced its Oric Pharmaceuticals (ORIC) stake by 12% in Q2 2026, selling an estimated $15.6K and leaving 12,798 shares worth $139K. The position accounts for ﹤0.01% of the portfolio, ranked #467.

E Fund Management first reported a position in ORIC in Q1 2026 and has held it in 2 quarters since. The position peaked at $184K in Q1 2026. 181 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • E Fund Management held 12,798 shares of Oric Pharmaceuticals worth $139K as of Q2 2026.
  • E Fund Management sold 1,719 Oric Pharmaceuticals shares in Q2 2026, an estimated $15.6K.
  • Oric Pharmaceuticals made up ﹤0.01% of E Fund Management's portfolio in Q2 2026, its #467 holding.
  • E Fund Management first reported a position in Oric Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • E Fund Management's Oric Pharmaceuticals position peaked at $184K in Q1 2026.
  • 181 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.